Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease
Authors:
Open Access
- 20 October 2020
- journal article
- research article
- Published by Wiley in Movement Disorders
- Vol. 36 (2) , 503-508
Abstract
Background: Outcomes are unpredictable for neurological presentations of Wilson's disease (WD). Dosing regimens for chelation therapy vary and monitoring depends on copper indices, which do not reflect end‐organ damage.Objective: To identify a biomarker for neurological involvement in WD.Methods: Neuronal and glial‐specific proteins were measured in plasma samples from 40 patients and 38 age‐matched controls. Patients were divided into neurological or hepatic presentations and those with recent neurological presentations or deterioration associated with non‐adherence were subcategorized as having active neurological disease. Unified WD Rating Scale scores and copper indices were recorded.Results: Unlike copper indices, neurofilament light (NfL) concentrations were higher in neurological than hepatic presentations. They were also higher in those with active neurological disease when controlling for severity and correlated with neurological examination subscores in stable patients.Conclusion: NfL is a biomarker of neurological involvement with potential use in guiding chelation therapy and clinical trials for novel treatments. © 2020 University College London. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder SocietyKeywords
Funding Information
- Canadian Institutes of Health Research
- H2020 European Research Council
- Guarantors of Brain
- Wellcome Trust
This publication has 16 references indexed in Scilit:
- Exchangeable copper: a reflection of the neurological severity in Wilson's diseaseEuropean Journal of Neurology, 2016
- Long-term metabolic correction of Wilson’s disease in a murine model by gene therapyJournal of Hepatology, 2016
- Early neurological worsening in patients with Wilson's diseaseJournal of the Neurological Sciences, 2015
- Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the Genetic Frontotemporal dementia Initiative (GENFI) study: a cross-sectional analysisThe Lancet Neurology, 2015
- Wilson's disease and other neurological copper disordersThe Lancet Neurology, 2015
- Role of the P-Type ATPases, ATP7A and ATP7B in brain copper homeostasisFrontiers in Aging Neuroscience, 2013
- EASL Clinical Practice Guidelines: Wilson’s diseaseJournal of Hepatology, 2012
- The pattern of urinary copper excretion and its response to treatment in patients with Wilson's diseaseQJM: An International Journal of Medicine, 2011
- Evaluation of the Unified Wilson's Disease Rating Scale (UWDRS) in German patients with treated Wilson's diseaseMovement Disorders, 2008
- Diagnosis and phenotypic classification of Wilson disease1Liver International, 2003